Feldschuh Jonathan Adam 4
4 · DAXOR CORP · Filed Jul 13, 2023
Insider Transaction Report
Form 4
DAXOR CORPDXR
Feldschuh Jonathan Adam
DirectorCHIEF SCIENTIFIC OFFICER
Transactions
- Award
Stock Options (right to buy)
2023-07-11+25,000→ 25,000 totalExercise: $9.88Exp: 2028-07-11→ COMMON STOCK (25,000 underlying)
Footnotes (2)
- [F1]Stock options granted on July 11, 2023 are contingent on the approval of the Securities & Exchange Commission ("SEC") to amend the Daxor Corporation 2020 Incentive Compensation Plan (the "Plan").
- [F2]The stock options will vest in three installments on July 11, 2024 (8,333), July 11, 2025 (8,333) and July 11, 2026 (8,334)